Replay available

Corbion NV (CSNVY) Q3 2025 Earnings Call

Corbion NV (OTC: CSNVY) Q3 2025 earnings conference call, held 2025-10-29. Replay captured from the company's public earnings webcast.

Wed, October 29, 2025 at 6:00 AMendedReplay
Corbion NV (CSNVY) Q3 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Olivier Rigaud

Chief Executive Officer

Peter Kazius

Chief Financial Officer

Wim Hosta

Analyst, KBC

Setu Sharda

Analyst, Barclays

Robert Jan Bos

Analyst, ABN Amro

Fernand de Boer

Analyst, Petercam

Sebastian Brey

Analyst, Berenberg

Eric Wilmer

Analyst, St. Lance Scott Campaign

Reg Watson

Analyst, ING

Replay transcript excerpt

Good morning and welcome to Corbian's third quarter 2025 results conference call. This morning we published our Q3 2025 interim management statement press release and presentation. These can be found on our website at corbian.com investor relations financial publications. With me on the call today are Olivier Rigaud, chief executive officer, and Peter Kazius, chief financial officer. Before we begin, please note that today's discussion will include forward-looking statements based on current expectations and assumptions. These statements involve risks and uncertainties that may cause actual results to differ materially from those expressed. Factors beyond our control, including market conditions, economic changes, and regulatory actions can impact outcomes. Corbian does not undertake any obligation to update statements made in this call or contained in today's press release. and presentation. For more details on our assumptions and estimates, please refer to our annual reports. Now, I would like to hand the call over to Olivier Rigaud. Olivier? Thanks, Alex, and good morning, everyone, and thank you for joining our Q3 2025 earnings call. We are pleased to report solid results for the first nine months of the year, which underscore the fundamental strength and resilience of our businesses. Our third quarter performance was in line with expectations, especially considering the strong comparable basis for Q3 2024 across both functional ingredient and solution and health and nutrition. We delivered meaningful margin expansion with adjusted EBITDA margins improving by 240 basis points year-to-date and 110 basis points in the quarter. These gains reflect the successful execution of our cost reduction initiatives, lower input prices for key materials, and our continued focu...

More from Corbion Nv